Current Event 

Register 
Overview
Pre-Conference Workshop
Day 1
Day 2
Alumni
Hotel & Travel
Posters
PDF Download
Sponsor & Exhibits 
Press Pass
Request Brochure
Archive 

Co-Located with
ctx_logo.jpg
April 13-14, 2010

AMS LinkedIn

Acasti 

IPM Integrated Project Mgt

QIAGEN

Vantage Partners

 

 

Current Partnering

Nature

 

PharmaVoice

Science AAAS


 

Biocentury logo

Biospace

PharmCast 

 

 


Alliance Management Congress

Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

Attendance is Running 25% Ahead of Last Year.  Register Today and Join the Rapidly Expanding List of Participants.

CHI’s successful Alliance Management Congress is growing! Our growth mirrors recent survey results collected from eighty-nine thought leaders in alliance management, diagnostics, medical devices, and licensing. In light of the economy and state of industry, 88% deem alliances as critical and essential to their organization’s alliance activity. Alliances in the personalized medicine arena along with new partner collaborations from academic institutions, diagnostics, medical devices, and international markets will increase 84% during the next 9-12 months. Read more 

Event Features:

  • Network with 125+ Attendees
  • Hear 20+ Presentations
  • Choose from Multiple Pre-conference Workshops
  • Connect with Attendees Using CHI’sintronet_logo
  • Build a Path for Commercialization of Diagnostics
  • And Much More!

Pre-Conference Workshops
April 12-13, 2010

Workshop 1: Serve, Collaborate, Disintermediate: Business Strategies for Companion Diagnostics

Workshop 2: Building Effective Infrastructure for Alliance Management Execution: Tools, Processes and Implementation Strategies that Work Best

Workshop 3: Life Cycle Management of Pharmaceuticals and Biologics

Presentations from:
AstraZeneca, Bayer Healthcare- Pharmaceuticals, Children’s Hostpital- Boston, Depomed, Inc., DxS Ltd,
Food and Drug Administration,
Functional Genetics, Genentech, Inc., Genzyme Corporation, Harvard Medical- School, Harvard Stem Cell Institute,
Isis Pharmaceuticals, Merck Research- Laboratories, National Jewish Health, PATH, PharmaVentures Ltd., Sanofi-Aventis, Shanghai Genomics,
The Ohio State University, Vantage- Partners Wyeth

 

combination_drug_therapies_logo

This meeting will attract Vice Presidents, Department Heads, Directors, and Managers of Alliance Management, Business Development, Licensing, R&D, Project Management, Clinical Development, and Drug Regulatory Affairs from pharmaceutical, biotech, diagnostics, and medical devices companies

Monday, April 12
(Afternoon Sessions)

Pre-Conference Workshops

Workshop 1 : 1:00-3:00pm
Serve, Collaborate, Disintermediate: Business Strategies for Companion Diagnostics

Workshop 2 : 3:30-5:30pm
Alliance Management Execution: Tools, Processes and Implementation Strategies that Work Best Sponsored by Vantage Partners

Tuesday, April 13
(Morning Session)

Alliance Management Congress

Tuesday, April 13
(Afternoon Session)

Alliance Management Congress
Combination Drug Therapies: Overcoming Challenges in the Development of Fixed Dose and Co-Packaged Combinations

Wednesday, April 14
(Morning Session)

Alliance Management Congress
Combination Drug Therapies: Overcoming Challenges in the Development of Fixed Dose and Co-Packaged Combinations

Wednesday, April 14
(Afternoon Session)

Alliance Management Congress
Combination Drug Therapies: Overcoming Challenges in the Development of Fixed Dose and Co-Packaged Combinations
 


Strategic Alliances - Report

By Series:
By Region: